Merck & Co’s TuHURA Biosciences HURA Stock Holding History

Merck & Co’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.5K	Hold	19,445	–	–	0.01%	12
2026 Q1	$34.8K	Buy	19,445 +5,495	+39%	+$6.73K	0.01%	14
2025 Q4	$10.6K	Hold	13,950	–	–	﹤0.01%	12
2025 Q3	$34.6K	Hold	13,950	–	–	0.02%	13
2025 Q2	$31.1K	Buy	+13,950	New	+$47.1K	0.01%	13

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Merck & Co's HURA Position: Q2 2026 in Review

Merck & Co held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 19,445 shares worth $45.5K. The position accounts for 0.01% of the portfolio, ranked #12.

Merck & Co first reported a position in HURA in Q2 2025 and has held it in 5 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Merck & Co held 19,445 shares of TuHURA Biosciences worth $45.5K as of Q2 2026.
Merck & Co left its TuHURA Biosciences share count unchanged in Q2 2026.
TuHURA Biosciences made up 0.01% of Merck & Co's portfolio in Q2 2026, its #12 holding.
Merck & Co first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 5 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Merck & Co's 13F filing for Q2 2026, filed 7 Aug 2026.